123 related articles for article (PubMed ID: 2950056)
1. Antagonism of bromocriptine-induced cage climbing behaviour in mice by the selective D-2 dopamine receptor antagonists, metoclopramide and molindone.
Balsara JJ; Nandal NV; Gada VP; Bapat TR; Chandorkar AG
Indian J Physiol Pharmacol; 1986; 30(1):85-90. PubMed ID: 2950056
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent response of central dopaminergic systems to metoclopramide in mice.
Bhosale KB; Balsara JJ; Gaonkar RK; Bhosale BB; Gupta SK
Indian J Exp Biol; 1997 Jun; 35(6):618-22. PubMed ID: 9357166
[TBL] [Abstract][Full Text] [Related]
3. Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine.
Sprah L; Zivin M; Sket D
J Pharmacol Exp Ther; 1999 Mar; 288(3):1093-100. PubMed ID: 10027846
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent response of central dopaminergic systems to buspirone in mice.
Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Gursale SC; Balsara JJ
Indian J Exp Biol; 2008 Oct; 46(10):704-14. PubMed ID: 19024168
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of the locomotor-sensitizing effects of the D2 dopamine agonist bromocriptine by either the D1 antagonist SCH 23390 or the D2 antagonist raclopride.
Wise RA; Carlezon WA
Synapse; 1994 Jul; 17(3):155-9. PubMed ID: 7974197
[TBL] [Abstract][Full Text] [Related]
7. Bromocriptine induces climbing behaviour: possible D-1 or D-2 dopamine receptor involvement.
Zarrindast MR; Shahed-Dirin K
Psychopharmacology (Berl); 1990; 100(2):275-80. PubMed ID: 2305016
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
Carey RM; Thorner MO; Ortt EM
J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
[TBL] [Abstract][Full Text] [Related]
9. Effects of yohimbine on dopamine dependent behaviours in rats and mice.
Bende MM; Bapat TR; Balsara JJ; Chandorkar AG
Indian J Physiol Pharmacol; 1990 Jul; 34(3):195-200. PubMed ID: 2286423
[TBL] [Abstract][Full Text] [Related]
10. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
Davidkova G; Zhou LW; Morabito M; Zhang SP; Weiss B
J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422
[TBL] [Abstract][Full Text] [Related]
11. Blockade of the dopamine depressor response by molindone, a newly introduced neuroleptic.
Nandal NV; Mane VR; Balsara JJ; Chandorkar AG
Indian J Physiol Pharmacol; 1980; 24(2):143-7. PubMed ID: 6103868
[TBL] [Abstract][Full Text] [Related]
12. Anti-aggressive effects of GHB in OF.1 strain mice: involvement of dopamine D2 receptors.
Pedraza C; Dávila G; Martín-López M; Navarro JF
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):337-42. PubMed ID: 17050057
[TBL] [Abstract][Full Text] [Related]
13. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
[TBL] [Abstract][Full Text] [Related]
14. Central bromocriptine-induced tachycardia is reversed to bradycardia in conscious, deoxycorticosterone acetate-salt hypertensive rats.
Lahlou S
Pharmacol Toxicol; 2001 May; 88(5):238-43. PubMed ID: 11393583
[TBL] [Abstract][Full Text] [Related]
15. Effects of buspirone on dopamine dependent behaviours in rats.
Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
[TBL] [Abstract][Full Text] [Related]
16. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
Khisti RT; Deshpande LS; Chopde CT
Psychopharmacology (Berl); 2002 May; 161(2):120-8. PubMed ID: 11981591
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of dopamine receptor-mediated responses by B-HT 920 in mice.
Chopra K; Kulkarni SK
Arch Int Pharmacodyn Ther; 1988; 294():46-55. PubMed ID: 2906798
[TBL] [Abstract][Full Text] [Related]
18. Postsynaptic dopamine/adenosine interaction: I. Adenosine analogues inhibit dopamine D2-mediated behaviour in short-term reserpinized mice.
Ferré S; Herrera-Marschitz M; Grabowska-Andén M; Ungerstedt U; Casas M; Andén NE
Eur J Pharmacol; 1991 Jan; 192(1):25-30. PubMed ID: 1828236
[TBL] [Abstract][Full Text] [Related]
19. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
[TBL] [Abstract][Full Text] [Related]
20. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
Capasso A; Sorrentino L
Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
